Robeco Institutional Asset Management B.V. Grows Position in Stryker Corporation $SYK

Robeco Institutional Asset Management B.V. lifted its position in shares of Stryker Corporation (NYSE:SYK) by 1.2% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 332,802 shares of the medical technology company’s stock after purchasing an additional 4,038 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.09% of Stryker worth $123,027,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in SYK. Two Point Capital Management Inc. bought a new stake in Stryker during the second quarter valued at about $7,281,000. Diversified Trust Co grew its position in shares of Stryker by 45.6% during the third quarter. Diversified Trust Co now owns 12,445 shares of the medical technology company’s stock worth $4,601,000 after purchasing an additional 3,899 shares in the last quarter. Alecta Tjanstepension Omsesidigt grew its position in shares of Stryker by 82.0% during the second quarter. Alecta Tjanstepension Omsesidigt now owns 458,300 shares of the medical technology company’s stock worth $181,235,000 after purchasing an additional 206,500 shares in the last quarter. SVB Wealth LLC bought a new stake in Stryker during the 2nd quarter valued at approximately $4,785,000. Finally, AXQ Capital LP purchased a new position in Stryker in the 2nd quarter worth approximately $567,000. Institutional investors own 77.09% of the company’s stock.

Insider Activity

In other news, CFO Preston Wendell Wells sold 165 shares of the firm’s stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the completion of the sale, the chief financial officer owned 6,694 shares in the company, valued at approximately $2,449,200.72. This trade represents a 2.41% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO William E. Berry, Jr. sold 1,953 shares of Stryker stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $365.49, for a total transaction of $713,801.97. Following the transaction, the chief accounting officer directly owned 2,833 shares of the company’s stock, valued at approximately $1,035,433.17. This represents a 40.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 522,118 shares of company stock valued at $185,381,932. 5.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Citizens Jmp raised shares of Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 price objective for the company in a report on Friday, December 19th. Wells Fargo & Company raised their target price on shares of Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a research note on Friday, November 14th. BTIG Research reiterated a “buy” rating and issued a $410.00 price target on shares of Stryker in a report on Friday, November 14th. Citigroup dropped their price objective on shares of Stryker from $455.00 to $420.00 and set a “buy” rating for the company in a report on Thursday, December 11th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. Fourteen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $430.40.

Stryker Price Performance

SYK stock opened at $366.46 on Wednesday. Stryker Corporation has a 52 week low of $329.16 and a 52 week high of $406.19. The firm has a market capitalization of $140.14 billion, a P/E ratio of 48.16, a price-to-earnings-growth ratio of 2.23 and a beta of 0.89. The company has a fifty day simple moving average of $359.75 and a two-hundred day simple moving average of $375.35. The company has a quick ratio of 1.13, a current ratio of 1.85 and a debt-to-equity ratio of 0.68.

Stryker (NYSE:SYK) last announced its earnings results on Friday, October 31st. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.13 by $0.06. The firm had revenue of $6.06 billion for the quarter, compared to analysts’ expectations of $6.04 billion. Stryker had a net margin of 12.07% and a return on equity of 24.07%. The business’s revenue was up 10.2% compared to the same quarter last year. During the same period in the prior year, the company earned $2.87 EPS. Analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be issued a $0.88 dividend. This is a positive change from Stryker’s previous quarterly dividend of $0.84. The ex-dividend date is Wednesday, December 31st. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. Stryker’s dividend payout ratio (DPR) is presently 46.25%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.